PROTHEGEN
Prothegen is a biotechnology company that develops cutting-edge medicines for precisely regulating cell death. The company is based in Palo Alto, California.
PROTHEGEN
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics
Address:
Palo Alto, California, United States
Country:
United States
Status:
Active
Total Funding:
0
Investors List
More informations about "Prothegen"
Prothegen 2025 Company Profile: Valuation, Funding …
Prothegen General Information Description. Developer of biotechnology platform intended to deliver therapies to regulate cell death with precision. The company's platform aims at developing therapeutics to inhibit or promote ferroptosis, …See details»
Prothegen: Designing Next Generation Medicines …
Apr 26, 2022 Equipped with the right mechanism, right location of action, and the right biomarkers, Prothegen is poised to introduce the next generation of medicines targeting ferroptosis. As I was checking out exhibits on Expo Day, I …See details»
Prothegen - VentureRadar
Founded by world leaders in ferroptosis, Prothegen is an early-stage biotech company delivering revolutionary therapies to regulate cell death with exquisite precision. Our first molecule, …See details»
Prothegen - Funding, Financials, Valuation & Investors - Crunchbase
Prothegen is a biotechnology company that develops cutting-edge medicines for precisely regulating cell death. New. Resources. ... Experience the new Crunchbase, powered by AI . …See details»
Prothegen - IndieBio - #1 in Early Stage Biotech
There’s thousands of ways that cells become unhealthy. But until 2012, there were only two ways that cells actually die. That year, the cofounder of Prothegen, Dr. Scott Dixon, discovered a new way cells die, called ferroptosis, an iron …See details»
Prothegen - Products, Competitors, Financials, Employees, …
Prothegen provides a biotechnology platform. It delivers therapies to regulate cell death (ferroptosis) to open new ways to treat diseases such as stroke, neurodegeneration, and …See details»
Prothegen - Crunchbase
Prothegen is a biotechnology company that develops cutting-edge medicines for precisely regulating cell death.See details»
Prothegen Inc. | LinkedIn
Founded by world leaders in ferroptosis, Prothegen is an early-stage biotech company delivering revolutionary therapies to regulate cell death with exquisite precision. Targeting new cell death …See details»
Prothegen, Inc.: Drug pipelines, Patents, Clinical trials - Synapse
Jul 13, 2023 Explore Prothegen, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Find an intro to Prothegen Inc. | Village
Prothegen is a biotechnology company that develops cutting-edge medicines for precisely regulating cell death. Basic info. Industry. biotechnology research. Sectors. Biotechnology. …See details»
PROTHEGEN INC. :: California (US) - OpenCorporates
Free and open company data on California (US) company PROTHEGEN INC. (company number 4807611), 726 SERRA ST, STANFORD, CA, 94305See details»
Prothegen (IndieBio SF Demo Day 12) - YouTube
Apr 26, 2022 Founded by world leaders in ferroptosis, Prothegen is an early-stage biotech company delivering revolutionary therapies to regulate cell death with exquisite...See details»
Prothegen Inc. Overview | SignalHire Company Profile
Prothegen Inc. industries. Biotech Headquarters Location. Serra St, Palo Alto, California, 94305 US. Prothegen Inc. Employees Size. 1-10 employees. Contact top employees from Prothegen …See details»
Targeting lipoxygenases to suppress ferroptotic cell death
Jul 18, 2023 D.A.P. is a scientific cofounder of Prothegen Inc. The company seeks to develop therapeutics targeting ferroptosis-related disease. D.A.P. owns stock in Prothegen Inc. and …See details»
Gold Rabbit Sports Announces Strategic Partnership With Bio …
Feb 8, 2023 About Prothegen. Prothegen is an early-stage biotech company delivering revolutionary therapies to regulate cell death with exquisite precision. Founded by academics …See details»
A Cell Cycle-Dependent Ferroptosis Sensitivity Switch ... - bioRxiv
Jul 19, 2023 ### Competing Interest Statement S.J.D. is a founder of Prothegen Inc., a member of the scientific advisory board of Ferro Therapeutics and Hillstream Biopharma, and an …See details»
Pre Seed Round - Prothegen - 2021-11-03 - Crunchbase
Nov 3, 2021 Prothegen raised an undisclosed amount on 2021-11-03 in Pre Seed Round. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. …See details»
WHO updates list of drug-resistant bacteria most threatening to …
May 17, 2024 The World Health Organization (WHO) today released its updated Bacterial Priority Pathogens List (BPPL) 2024, featuring 15 families of antibiotic-resistant bacteria …See details»
First global pandemic treaty agreed — without the US - Nature
1 day ago The World Health Organization accord promotes sharing scientific data in exchange for more equitable distribution of drugs and vaccines. The World Health Organization accord …See details»
WHO to identify pathogens that could cause future outbreaks and …
Nov 21, 2022 | WHO is launching a global scientific process to update the list of priority pathogens—agents that can cause outbreaks or pandemics—to guide global investment, …See details»